Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
Recent advances in genomics and genetic engineering have led to a plethora of new insights and discoveries about human history, evolution, and migrations, as well as to the unmasking of fundamental information about people's unique traits - including their likenesses and differences, as well as their varying susceptibilities to diseases. Nowhere has this been more striking than in the field of infectious diseases, where human genomic differences can now be leveraged to manufacture transmissible microorganisms that can infect people selectively while leaving other people unscathed. The result…mehr
Recent advances in genomics and genetic engineering have led to a plethora of new insights and discoveries about human history, evolution, and migrations, as well as to the unmasking of fundamental information about people's unique traits - including their likenesses and differences, as well as their varying susceptibilities to diseases. Nowhere has this been more striking than in the field of infectious diseases, where human genomic differences can now be leveraged to manufacture transmissible microorganisms that can infect people selectively while leaving other people unscathed. The result is a rapidly increasing potential for the precise targeting of biological warfare agents against both adversaries and ordinary citizens alike. All that is necessary is to identify systematic differences in the genomic make-up of different people and societal subgroups to develop microbiologic agents that will target their unique genomic characteristics selectively. In the wrong hands, such capabilities can be used to control both the attitudes and behaviors of entire human populations, and to subjugate and conquer them. These new gene editing techniques mean that biological warfare agents have a new capability that permits person-specific viruses to be created and dispersed to find their "targets." Moreover, those who control the libraries of human genomic information can selectively target anyone, anywhere, anytime, for any reason - all without risk of traceability, accountability, or culpability. As early attempts to humanize viruses such as SARS (SARS CoV-1), MERS (MERS-CoV), and COVID-19 (SARS CoV-2) have demonstrated, guarding against the use of weaponized viruses for such malign control of individuals and even whole societies will be the next great challenge faced by humanity.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, D ausgeliefert werden.
Die Herstellerinformationen sind derzeit nicht verfügbar.
Autorenporträt
Gerard G. Nahum, MD relies on his training as a physician, engineer, and pharmaceutical developer for inspiration. While an undergraduate, medical student, and professor at Yale, Stanford, and Duke Universities, he published more than sixty peer-reviewed scientific and medical articles. More recently, he has authored three nonfiction books, two children's books, one novel, and one work of science fiction.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826